‘Smart bomb’ drug delivery may boost effectiveness of prostate cancer imagingApril 22nd, 2009 - 1:24 pm ICT by ANI
Washington, Apr 22 (ANI): Researchers from Johns Hopkins University have identified a novel way to combine imaging with chemotherapy in a single agent for the treatment of prostate cancer.
According to lead researcher Dr John P. Sedelaar, a postdoctoral research fellow at Johns Hopkins University, conventional methods include multimodality MRI to examine the urological system for diagnosing prostate cancer.
However, this tool is mostly thought of as a prostate imaging method, rather than a prostate cancer imaging method.
“An increasing number of patients have minimal prostate cancer, and opt for either very focused treatment or the watchful waiting approach,” said Sedelaar.
“In this environment, the need for an accurate imaging tool is paramount,” he added.
The researchers have designed two imaging drugs: a PSMA and a PSA-activated pro-drug. These agents are therapeutic drugs that are modified by adding a tyrosine ring for imaging.
After administrating the drugs to laboratory mice, researchers noted a measureable reduction in prostate cancer cells.
“It’s like a smart bomb, to use a military analogy,” said Sedelaar.
“By retooling chemotherapy agents, we may be able to get more accurate treatment monitoring and follow-up,” he added.
The study showed that the imaging pro-drugs were cleaved and activated by PSMA or PSA, suggesting their viability as a prostate cancer imaging modality.
The study was presented at American Association for Cancer Research 100th Annual Meeting 2009. (ANI)
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Now, test to predict aggressiveness of prostate cancer - Apr 20, 2010
- PSA test more reliable in men taking prostate-shrinking drug - Dec 18, 2010
- New test accurately detects aggressive prostate cancer - Apr 07, 2011
- New ultrasound technology can accurately spot prostate cancer tumours - Dec 09, 2010
- New method detects aggressive prostate cancer - Aug 09, 2012
- Heart drug cuts prostate cancer risk - Apr 03, 2011
- New way of treating lung cancer soon - Oct 11, 2011
- Most men unaware of blood test for prostate cancer, finds charity - Mar 01, 2011
- Change in PSA level poor predictor of prostate cancer - Feb 25, 2011
- Cardiac drug, digoxin, could lower risk for prostate cancer - Apr 04, 2011
- New treatment shows promise in the fight against breast cancer - Mar 30, 2011
- New drugs to kill cancers minus side-effects - May 21, 2012
- Drug for rare childhood cancer may help prevent prostate cancer spread - Apr 30, 2011
- New treatment strategy effective for certain lung cancers - Mar 11, 2011
Tags: accurate treatment, cancer research, chemotherapy, chemotherapy agents, conventional methods, dr john, drug delivery, johns hopkins university, laboratory mice, modality, postdoctoral research fellow, prostate cancer, prostate cancer cells, prostate cancer imaging, psma, smart bomb, therapeutic drugs, treatment of prostate cancer, tyrosine, viability